Brind.

Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.

4 reports, 3 independent Updated May 27
Gone quiet Reached 3 outlets in its first 24 hours
Reports
4
Developments
3
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Telix Pharmaceuticals Limited is headquartered in Melbourne, Australia, and an executive is attending a conference in Chicago.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Telix Pharmaceuticals Limited is involved in activities related to Europe.Sub-event
  2. Telix Pharmaceuticals is headquartered in Melbourne, Australia, with an executive attending a conference in Chicago.1 source
  3. Telix is seeking global trial expansion and reporting commercial performance from Indianapolis.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • GlobeNewswireTelix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOB
  • PR NewswireTelix H1 2025 Results: Investor Webcast Notification MELBOURNE, Australia and INDIANAPOLIS, July 30, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises
  • GlobeNewswireTelix Reports $204M Revenue, Up 63% YOY MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an updat